Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-10-03
1988-11-01
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514253, 514260, 514275, 514285, 5142332, 540481, 540597, 544125, 544284, 544332, 544361, 546 70, A61K 3155, A61K 31535, C07D47104
Patent
active
047820527
ABSTRACT:
The invention relates to new 1,2,3,4,6,7,12,12b-octahydroindolo[2,3,-a]quinolizin-1-yl-alkanecarboxylic acid amides of the formula (I), ##STR1## wherein R.sub.1 and R.sub.2 stand independently for a hydrogen or halogen atom, or a hydroxyl, nitro or C.sub.1-4 alkoxy group;
REFERENCES:
patent: 4117133 (1978-09-01), Bonati et al.
patent: 4353911 (1982-10-01), Buzas
Balogh, et al., Chem. Abstracts, vol. 105, (1986), entry 60794h.
Balogh nee Kardos Zsuzsanna
Ezer Elemer
Hajos Gyorgy
Incze Maria
Kuthi Csaba
Daus Donald G.
Dubno Herbert
Myers Jonathan
Richter Gedeon Vegyeszeti Gyar Rt.
Teoli, Jr. William A.
LandOfFree
Octahydroindolo[2,3-a]quinolizin-1-yl-alkanecarboxylic acid amin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Octahydroindolo[2,3-a]quinolizin-1-yl-alkanecarboxylic acid amin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Octahydroindolo[2,3-a]quinolizin-1-yl-alkanecarboxylic acid amin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-890952